Colorectal cancer is the second most common cause of cancer death in western Europe and North America. It is now recognised that the long-term survival of patients with colorectal cancer is dependent not only on pathological stage but also on complex interactions between tumour- and patient-related factors. In particular, the host inflammatory responses, both systemic and local, are important determinants of cancer outcome. A pronounced systemic inflammatory response has been consistently associated with reduced survival in a number of solid organ tumour types, including colorectal cancer, and has now been rationalised into a simple and reliable prognostic tool, termed the modified Glasgow Prognostic Score (mGPS; [@bib9]; [@bib23]).

In contrast to the systemic response, local infiltration of inflammatory cells in the tumour microenvironment is associated with improved survival in patients with colorectal cancer. However, despite extensive investigation over a 40-year period, a reliable measure of the local inflammatory cell infiltrate has yet to be incorporated into clinical practice ([@bib10]; [@bib19]; [@bib4]). To establish routine clinical utility there is, therefore, a need to standardise the assessment of the local inflammatory cell response in colorectal tumours.

A logical starting point would be to compare the prognostic value and clinicopathological associations of individual immune cell types with a more generalised assessment of local inflammation. Indeed, a global assessment of peritumoural inflammatory cell infiltrate, using routine haematoxylin and eosin (H&E)-stained sections, has been proposed by [@bib11] (Klintrup--Makinen grade, K--M grade) and independently validated by [@bib25].

The aim of the present study, therefore, was to examine the relationships between overall K--M grade, individual inflammatory cell components and survival in patients with primary operable colorectal cancer.

Materials and methods
=====================

Patients with colorectal cancer who, on the basis of preoperative staging and laparotomy findings, were considered to have undergone potentially curative resection of colorectal cancer (stages I--III) between January 1997 and December 2006 in a single surgical unit at Glasgow Royal Infirmary were included. The patients were identified from a prospectively maintained database of elective and emergency resections. Exclusion criteria were: (i) clinical evidence of active infection, (ii) presence of a chronic inflammatory condition, (iii) preoperative chemoradiotherapy and (iv) death within 30 days of surgery.

Routine laboratory measurements of haemoglobin, differential white blood cell count, albumin and C-reactive protein (CRP) were recorded before surgery. Using local reference ranges, anaemia was defined as a haemoglobin concentration \<13.0 g dl^−1^ in men and \<11.5 g dl^−1^ in women, and severe anaemia as \<11.0 g dl^−1^ in men and \<10.0 g dl^−1^ in women. The systemic inflammatory response was assessed using the mGPS and has been described previously ([@bib13]). Briefly, patients with both a raised CRP level (\>10 mg l^−1^) and a low albumin (\<35 g l^−1^) were allocated a score of '2\'. Patients with a raised level of CRP alone were scored '1\'. Patients with normal values or hypoalbuminaemia alone were scored '0\'.

The tumours were staged according to the fifth edition of the tumour, node and metastases (TNM) classification ([@bib3]). Additional pathological data were taken from reports issued at the time of resection. With regard to venous invasion, cases in the present study that predated the introduction of routine elastica staining at Glasgow Royal Infirmary in 2003 were stained and reported retrospectively. Tumour necrosis had been assessed in the cohort previously according to published methodology ([@bib22]). Briefly, the extent of necrosis in the central tumour was assessed semi-quantitatively and graded as 'absent\' (none), 'focal\' (\<10% of tumour area), 'moderate\' (10--30%) or 'extensive\' (\>30%).

The peritumoural inflammatory cell infiltrate had also been assessed previously in the cohort according to the K--M criteria (inter-observer intraclass correlation coefficient 0.81; [@bib25]). Briefly, original H&E-stained sections (median 3, range 2--5) were selected from areas of the central tumour felt to represent the maximum depth of tumour invasion. The invasive margin of each tumour was then scored on a four-point scale. A score of '0\' indicated no increase in inflammatory cells; score '1\' denoted a mild or patchy increase, score '2\' a prominent inflammatory reaction, and score '3\' a florid 'cup-like\' inflammatory infiltrate. The peritumoural inflammatory cell response was subsequently classified as low grade (score 0--1) or high grade (score 2--3).

The following method was then used to identify individual inflammatory cells. The original H&E-stained sections used for the K--M grading were retrieved from pathology archives and a representative section was chosen for a more detailed analysis. This section was converted to electronic format using a high-resolution digital scanner (Slidepath Digital Image Hub v3, Wetzlar, Germany) before five distinct areas (560*μ*m × 250*μ*m) were selected at intervals along the invasive margin. Gridlines (42*μ*m × 42*μ*m) were digitally superimposed and individual cells were counted in 10 random boxes within each of the areas (∼0.018 mm^2^). This resulted in a total of 50 boxes (∼0.09 mm^2^) being analysed per patient. For the purposes of deciding if a cell which straddled a gridline was within a box or not, two perpendicular lines were considered 'inclusion\' lines and only cells touching these lines were included ([@bib7]). Cellular identification put each cell into one of the six categories: lymphocyte, plasma cell, neutrophil, macrophage (including mast cells), eosinophil or other (which included neoplastic, stromal, endothelial, necrosed or unidentifiable cells). The cells were counted using image analysis software (ImageJ available at <http://rsbweb.nih.gov/ij/>). A total of 20 cases were scored independently by two observers to confirm consistency of scoring. The inter-observer intraclass correlation coefficients for each cell type were: lymphocytes 0.92, plasma cells 0.80, neutrophils 0.65, macrophages 0.40 and eosinophils 0.92.

Patients were followed up for 5 years after surgery. Information on date and cause of death was cross-checked with that received by the cancer registration system and the Registrar General (Scotland). Death records were complete until 1 December 2010, which served as the censor date. Cancer-specific survival was measured from the date of surgery until the date of death from colorectal cancer. The authors confirm that this study was approved by the West of Scotland Research Ethics Committee, Glasgow with written informed consent obtained from all participants.

Statistical analysis
--------------------

The inflammatory cell types were divided into two equal groups termed 'low\' and 'high\' based on the median cell count per 0.018 mm^2^. Grouping of other variables was carried out using standard or previously published thresholds. Associations between categorical and continuous variables were examined using *χ*^*2*^ tests for linear trend and non-parametric tests. Survival analyses were performed using the Kaplan--Meier method and Cox proportional hazards regression. Variables significant on univariate analysis were entered into a multivariate model using a backwards conditional method. *P*-value \<0.050 was considered statistically significant. Statistical analyses were performed using SPSS version 19.0 (IBM SPSS, Chicago, IL, USA).

Results
=======

A total of 130 patients who underwent potentially curative resection of colorectal cancer were included. The majority of patients were 65 years or older (68%) with a similar number of males (52%) and females (48%). Most operations were elective (94%) and were carried out for both colon (68%) and rectal cancer (32%). The preoperative systemic inflammatory response was graded as mGPS 0 in 68 patients (52%), 1 in 47 (36%) and 2 in 15 (12%). Original pathological reports classified the 8% of the tumours as stage I, 49% as stage II and 43% as stage III. Using elastin staining, there was evidence of intra- or extramural venous invasion in 43 of the tumours (33%). In the postoperative period, a total of 38 patients (29%) received adjuvant chemotherapy.

Application of the K--M criteria graded the peritumoural inflammatory cell response as 'low grade\' in 63 patients (48%) and 'high grade\' in 67 patients (52%). The distribution of individual inflammatory cell types in the invasive margin are summarised in [Table 1](#tbl1){ref-type="table"}. The cells identified were primarily macrophages, lymphocytes and neutrophils with relatively few plasma cells or eosinophils ([Table 1](#tbl1){ref-type="table"}).

The relationships between overall K--M grade and individual inflammatory cell types are shown in [Figure 1](#fig1){ref-type="fig"}. There were significant relationships between high K--M grade and increased numbers of lymphocytes (*P*\<0.001), plasma cells (*P*\<0.001), neutrophils (*P*\<0.01) and eosinophils (*P*\<0.01). There was no relationship between K--M grade and macrophage count ([Figure 1](#fig1){ref-type="fig"}).

The median follow-up for the survivors was 105 months (range 55--163). During this period, 37 patients died from colorectal cancer and 34 patients died from other causes. The survival analyses for K--M grade and individual inflammatory cell types are shown in [Table 2](#tbl2){ref-type="table"}. On univariate analysis, K--M grade (*P*\<0.01), lymphocyte infiltration (*P*\<0.05) and plasma cell infiltration (*P*\<0.01) were significantly associated with cancer-specific survival. The Kaplan--Meier survival curves demonstrating these relationships are shown in [Figure 2](#fig2){ref-type="fig"}.

K--M grade, lymphocyte infiltration and plasma cell infiltration were then entered into a multivariate survival model with standard clinical and pathological variables ([Table 3](#tbl3){ref-type="table"}). This demonstrated that systemic inflammatory response (mGPS; HR 2.27, *P*\<0.01), TNM stage (HR 1.97, *P*\<0.05), venous invasion (HR 2.03, *P*\<0.05), tumour necrosis (HR 1.54, *P*\<0.05) and K--M grade (HR 2.38, *P*\<0.05) were independently associated with cancer-specific survival ([Table 3](#tbl3){ref-type="table"}). When patients with node-negative disease were considered alone, only systemic inflammatory response (mGPS; HR 2.46, *P*\<0.05) and K--M grade (HR 3.67, *P*\<0.05) were independently associated with cancer-specific survival (data not shown).

The relationships between K--M grade, individual inflammatory cell types and patient-related variables are shown in [Table 4](#tbl4){ref-type="table"}. No relationships were observed between either K--M grade or lymphocyte infiltration and any of the patient-related variables studied, including markers of the systemic inflammatory response. There was a significant association between plasma cell infiltration and serum neutrophil count (*P*\<0.05; [Table 4](#tbl4){ref-type="table"}).

The relationships between K--M grade, individual inflammatory cell types and tumour-related variables are shown in [Table 5](#tbl5){ref-type="table"}. There were significant relationships between K--M grade and T stage (*P*\<0.01), N stage (*P*\<0.05), TNM stage (*P*\<0.05), venous invasion (*P*\<0.05), tumour necrosis (*P*\<0.05) and margin characteristics (*P*\<0.001). For individual cell types, there were significant relationships between lymphocyte infiltration, venous invasion (*P*\<0.05) and margin characteristics (*P*\<0.01). Similarly, there were significant relationships between plasma cell infiltration and N stage (*P*\<0.05), TNM stage (*P*\<0.05), venous invasion (*P*\<0.01), tumour necrosis (*P*\<0.05) and margin characteristics (*P*\<0.05; [Table 5](#tbl5){ref-type="table"}).

Discussion
==========

Results from the present study demonstrate that a strong infiltration of inflammatory cells in the invasive margin of colorectal tumours confers a distinct survival advantage for patients with primary operable colorectal cancer. Furthermore, although a strong overall inflammatory cell infiltrate is a superior predictor of prognosis than the analysis of individual cell types, high numbers of lymphocytes and plasma cells in particular are beneficial to survival and associated with a number of favourable pathological characteristics. Taken together, these results indicate a prominent role for a coordinated adaptive immune response in the prevention of tumour progression in colorectal cancer.

A large number of previous studies, published over a 40-year period, have examined the prognostic value of inflammatory cell infiltration in colorectal cancer ([@bib24]). Despite this volume of work, there is still no standardised method for the assessment of the local inflammatory response in colorectal tumours. This lack of consensus may be partly explained by the fact that many previous studies have concentrated on single cell types ([@bib17]; [@bib21]; [@bib4]), have relied on tissue microarrays ([@bib19]; [@bib5]; [@bib26]) or have employed immunohistochemical techniques ([@bib18]; [@bib14]; [@bib27]). Importantly, few previous studies have directly compared two different methods for assessing the local inflammatory response on full H&E-stained sections.

If such assessments are to move from experimental research into clinical practice, the technique employed must be simple, reproducible and easy to validate and incorporate into existing pathological staging systems. The present study suggests that a simplified overall assessment of peritumoural inflammation, using the K--M grade, fulfils these criteria and is a superior predictor of prognosis than an assessment of individual inflammatory cell types.

In addition to comparing the prognostic value of the methods described above, the present study also included a detailed examination of the cellular composition of the invasive margin of colorectal tumours. When all patients were considered, macrophages were the most prevalent cell type, followed closely by lymphocytes and neutrophils. When the cellular composition was re-examined in patients with a high-grade peritumoural inflammatory response, the relative proportion of lymphocytes increased whereas the proportions of neutrophils and macrophages fell. These findings suggest that such patients are mounting a coordinated inflammatory response at a local level, mediated primarily though cells associated with adaptive immunity.

The mechanisms by which a strong local adaptive immune response improves prognosis in patients with colorectal cancer are not clear. The present study found no association between an infiltration of inflammatory cells and any of the patient-related variables examined. In particular, there were no direct relationships with circulating levels of serum leukocytes or a systemic inflammatory response, as measured by the mGPS. These findings may therefore suggest a model whereby the initial stimulus for the development of a local inflammatory cell response is evoked by events within the tumour and its microenvironment ([@bib16]). In the case of a nonspecific immune cell reaction, this may include local tissue damage caused directly by tumour invasion with subsequent hypoxia, cellular necrosis and the release of pro-inflammatory cytokines ([@bib22]). Alternatively, a beneficial adaptive immune cell response may be triggered by altered antigenicity of the tumour cells themselves ([@bib6]). Indeed, the presence of lymphocytes in the present study was associated with a number of favourable tumour characteristics including an expanding rather than infiltrative growth pattern, a feature previously reported as an independent prognostic factor in colorectal cancer ([@bib2]). An association between intra-tumoural lymphocytes and lower levels of venous invasion has been reported previously ([@bib19]), and the present results suggest this relationship also exists with lymphocyte infiltration at the invasive margin. That this finding has not been reported previously may be explained by the use of elastica staining in the present study to aid the detection of venous emboli; a technique resulting in a higher prevalence of venous invasion than seen in many previous studies ([@bib25]).

In contrast to cells associated with the adaptive immune response, an abundance of neutrophils or macrophages at the tumour border did not influence survival in the present cohort. Evidence regarding the prognostic value of these cell types, intimately associated with the innate immune response, has been conflicting. Although a number of studies have suggested that a strong infiltration of neutrophils ([@bib1]) and macrophages ([@bib4]) is beneficial to patients with colorectal cancer, others have reported no relationship with survival ([@bib16]; [@bib15]). Indeed, in certain situations tumours may exploit these innate inflammatory cells to promote tumour proliferation and invasion ([@bib20]). Rather than reflecting a protective host response, the presence of these cell types in the tumour microenvironment then favours tumour growth and dissemination ([@bib12]). However, using H&E-stained slides it is difficult to identify and assess the degree of macrophage infiltration. Further work using immunohistochemistry may be required to examine the prognostic value of tumour-associated macrophages, although there should be careful consideration of the markers to be used as some, such as CD68, may be expressed by other non-myeloid tissues in cancer specimens ([@bib8]).

The present study has a number of limitations. The identification and classification of individual cell types on H&E-stained sections is a time consuming process, limiting patient numbers and restricting potential clinical application. However, this level of detail was required to compare the two methods and we can now confirm that a laborious examination of individual cells offers no additional prognostic information compared with a simplified global assessment of inflammation. The present study focused only on the invasive margin and did not assess inflammatory cells within the tumour itself. The primary reason for this approach is that the tumour border is felt to represent a critical interface between pro- and anti-tumour factors ([@bib28]). Furthermore, inflammatory cells within the tumour itself are difficult to identify on H&E-stained sections and there is currently no global assessment of intra-tumoural inflammation against which to make a comparison. Nevertheless, an examination of the prognostic value of intra-tumoural inflammatory cells, using immunohistochemical techniques, is of considerable interest and will be the subject of future work.

In summary, the present study confirms that a simple assessment of peritumoural inflammation, using the K--M grade, has independent prognostic value in patients with primary operable colorectal cancer. The examination of individual cell types does not improve prediction of outcome but does suggest a prominent role for a coordinated adaptive immune response in the prevention of tumour progression in these patients. Taken together these findings give additional support to the prognostic significance of the local inflammatory response in colorectal cancer and to the idea that a simple overall assessment of peritumoural inflammation could be applied in clinical practice.

We thank the 'Think Pink\' charity for providing funding to purchase the NanoZoomer Digital Pathology system and the Slidepath Digital Image Hub software.

This work is published under the standard license to publish agreement. After 12 months the work will become freely available and the license terms will switch to a Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License.

The authors declare no conflict of interest.

![Boxplot representation of the relationships between individual inflammatory cell types and K--M grade; lymphocytes (*P*\<0.001, Mann--Whitney *U*-test), plasma cells (*P*\<0.001), neutrophils (*P*=0.002), macrophages (*P*=0.21) and eosinophils (*P*=0.001).](bjc2012211f1){#fig1}

![Kaplan--Meier survival curves demonstrating the relationships between K--M grade (*P*=0.001, log-rank test), lymphocyte infiltration (*P*=0.041, log-rank test), plasma cell infiltration (*P*=0.001, log-rank test) and cancer-specific survival.](bjc2012211f2){#fig2}

###### Distribution of individual inflammatory cell types in the invasive margin of colorectal tumours

  **Cell type**                       ***N***   **Cell count,**[a](#t1-fn1){ref-type="fn"} **median (range)**   **% Of all cells, mean (95% CI)**
  ----------------------------------- --------- --------------------------------------------------------------- -----------------------------------
  Macrophages                         130       19 (6--49)                                                      22 (21--23)
  Lymphocytes                         130       17 (2--86)                                                      21 (20--23)
  Neutrophils                         130       15 (1--78)                                                      18 (16--20)
  Plasma cells                        130       9 (1--41)                                                       11 (10--12)
  Eosinophils                         130       1 (0--14)                                                       2 (1--2)
  Others[b](#t1-fn2){ref-type="fn"}   130       19 (5--55)                                                      22 (20--24)

Abbreviation: CI=confidence interval.

Cell count per 0.018 mm^2^.

Including neoplastic cells, stromal cells and endothelial cells.

###### The relationships between K--M grade, individual inflammatory cell types and cancer-specific survival (univariate survival analysis)

                                  **Univariate**    
  ----------------------------- ------------------- -------
  *Peritumoural inflammation*                       
   K--M low grade                3.13 (1.53, 6.38)  0.002
   K--M high grade                     1.00          
  *Lymphocytes*                                     
   Low                           1.98 (1.02, 3.86)  0.045
   High                                1.00          
  *Plasma cells*                                    
   Low                           2.99 (1.49, 5.99)  0.002
   High                                1.00          
  *Neutrophils*                                     
   Low                           1.45 (0.75, 2.81)  0.27
   High                                1.00          
  *Macrophages*                                     
   Low                           1.38 (0.71, 2.68)  0.34
   High                                1.00          
  *Eosinophils*                                     
   Low                           1.72 (0.89, 3.35)  0.11
   High                                1.00          

Abbreviations: CI=confidence interval; K--M=Klintrup--Makinen.

###### The relationships between clinicopathological characteristics and cancer-specific survival (multivariate survival analysis)

                                                            **Univariate**    **Multivariate**                       
  ------------------------------------------------------- ------------------- ------------------ ------------------- -------
  Sex (female/male)                                        1.15 (0.60, 2.19)  0.68                                    
  Age (⩽64/65--74/⩾75 years)                               1.30 (0.87, 1.96)  0.20                                    
  Presentation (elective/emergency)                        1.79 (0.55, 5.87)  0.34                                    
  Smoking (never/ex/current)                               1.19 (0.73, 1.95)  0.49                                    
  Anaemia (none/mild/severe)                               0.97 (0.60, 1.57)  0.91                                    
  Systemic inflammatory response (mGPS 0/1/2)              2.40 (1.55, 3.73)  \<0.001             2.27 (1.36, 3.80)  0.002
  Tumour site (colon/rectum)                               0.72 (0.34, 1.53)  0.39                                    
  TNM stage (I/II/III)                                     2.25 (1.24, 4.05)  0.007               1.97 (1.01, 3.82)  0.046
  Differentiation (well or mod/poor)                       2.47 (1.12, 5.43)  0.024                                  0.12
  Venous invasion (no/yes)                                 2.38 (1.24, 4.54)  0.009               2.03 (1.02, 4.06)  0.044
  Tumour necrosis (absent/focal/moderate/extensive)        2.02 (1.36, 2.99)  \<0.001             1.54 (1.02, 2.33)  0.038
  Character or margin (expanding/infiltrating)             2.25 (1.16, 4.34)  0.016                                  0.29
  Peritumoural inflammation (K--M high grade/low grade)    3.13 (1.53, 6.38)  0.002               2.38 (1.08, 5.22)  0.031
  Lymphocytes (high/low)                                   1.98 (1.02, 3.86)  0.045                                  0.36
  Plasma cells (high/low)                                  2.99 (1.49, 5.99)  0.002                                  0.54

Abbreviations: CI=confidence interval; K--M=Klintrup--Makinen; mGPS=Glasgow Prognostic Score; TNM=tumour, node and metastasis.

###### The relationships between K--M grade, lymphocyte infiltration, plasma cell infiltration and patient-related variables

  **Variable**                              **K--M grade (low/high)**   ***P***   **Lymphocytes (low/high)**   ***P***   **Plasma cells (low/high)**   ***P***
  ----------------------------------------- --------------------------- --------- ---------------------------- --------- ----------------------------- ---------
  *Sex*                                                                 0.71                                   1.00                                    0.48
   Male                                     34/34                                 34/34                                  32/36                          
   Female                                   29/33                                 31/31                                  33/29                          
                                                                                                                                                        
  *Age (years)*                                                         0.92                                   0.91                                    0.59
   ⩽64                                      19/22                                 17/24                                  19/22                          
   65--74                                   25/22                                 30/17                                  23/24                          
   \>75                                     19/23                                 18/24                                  23/19                          
                                                                                                                                                        
  *Presentation*                                                        0.17                                   1.00                                    0.47
   Elective                                 61/61                                 61/61                                  60/62                          
   Emergency                                2/6                                   4/4                                    5/3                            
                                                                                                                                                        
  *Smoking status*                                                      0.28                                   0.13                                    0.37
   Never                                    21/30                                 21/30                                  24/27                          
   Ex                                       18/15                                 20/13                                  14/19                          
   Current                                  11/10                                 12/9                                   13/8                           
                                                                                                                                                        
  *Anaemia*                                                             0.56                                   0.41                                    0.41
   Mild                                     25/31                                 27/29                                  30/26                          
   Moderate                                 8/15                                  14/9                                   8/15                           
   Severe                                   15/13                                 10/18                                  13/15                          
                                                                                                                                                        
  *Serum leukocytes ( × 10*^*9*^*/l)*                                                                                                                   
   White blood cell count                   9.3/8.9                     0.63      9.3/8.8                      0.50      9.7/8.4                       0.11
   Neutrophils                              6.8/5.9                     0.12      6.8/5.8                      0.10      6.9/5.7                       0.037
   Lymphocytes                              1.5/1.6                     0.21      1.5/1.6                      0.64      1.6/1.5                       0.24
                                                                                                                                                        
  *Systemic inflammatory response (mGPS)*                               0.50                                   0.70                                    0.16
   0                                        30/38                                 35/33                                  30/38                          
   1                                        26/21                                 23/24                                  26/21                          
   2                                        7/8                                   7/8                                    9/6                            

Abbreviations: GPS=Glasgow Prognostic Score; K--M=Klintrup--Makinen.

###### The relationships between K--M grade, lymphocyte infiltration, plasma cell infiltration and tumour-related variables

  **Variable**            **K--M grade (low/high)**   ***P***   **Lymphocytes (low/high)**   ***P***   **Plasma cells (low/high)**   ***P***
  ----------------------- --------------------------- --------- ---------------------------- --------- ----------------------------- ---------
  *Tumour site*                                       0.67                                   0.09                                    0.85
   Colon                  42/47                                 40/49                                  44/45                          
   Rectum                 21/20                                 25/16                                  21/20                          
                                                                                                                                      
  *T stage*                                           0.001                                  0.41                                    0.06
   T1/2                   1/14                                  6/9                                    4/11                           
   T3/4                   62/53                                 59/56                                  61/54                          
                                                                                                                                      
  *N stage*                                           0.039                                  0.72                                    0.03
   N0                     30/44                                 38/36                                  31/43                          
   N1/2                   33/23                                 27/29                                  34/22                          
                                                                                                                                      
  *TNM stage*                                         0.006                                  0.78                                    0.024
   I                      1/9                                   5/5                                    3/7                            
   II                     29/35                                 33/31                                  28/36                          
   III                    33/23                                 27/29                                  34/22                          
                                                                                                                                      
  *Differentiation*                                   0.72                                   0.48                                    0.83
   Well/moderate          53/57                                 54/56                                  55/55                          
   Poor                   10/9                                  11/8                                   9/10                           
                                                                                                                                      
  *Venous invasion*                                   0.008                                  0.016                                   0.005
   No                     35/52                                 37/50                                  36/51                          
   Yes                    28/15                                 28/15                                  29/14                          
                                                                                                                                      
  *Tumour necrosis*                                   0.018                                  0.11                                    0.010
   Absent                 3/7                                   6/4                                    2/8                            
   Focal                  26/33                                 26/33                                  27/32                          
   Moderate               20/22                                 19/23                                  23/19                          
   Extensive              13/4                                  14/3                                   12/5                           
                                                                                                                                      
  *Character or margin*                               \<0.001                                0.009                                   0.016
   Expanding              25/53                                 32/46                                  32/46                          
   Infiltrating           37/14                                 33/18                                  32/19                          

Abbreviations: K--M=Klintrup--Makinen; TNM=tumour, node and metastases.
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